Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

LeMaitre Vascular Sees Q2 GAAP EPS $0.55-$0.59 vs $0.58 Est; Sees Sales $61.500M-$63.500M vs $60.87M Est

Author: Benzinga Newsdesk | May 01, 2025 03:13pm
LeMaitre Vascular (NASDAQ:LMAT) is looking for Q2 GAAP EPS of $0.55-$0.59 vs $0.58 analyst estimate. sees sales of $61.500 million-$63.500 million vs $60.87 million analyst estimate.

Posted In: LMAT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist